The Alliance of Community Health Plans (ACHP) has submitted a comment letter about the U.S. Patent and Trademark’s Office (USPTO) initiatives to ensure the robustness and reliability of patent rights. In the letter, ACHP urges USPTO to consider several reforms to address the high cost of drugs.
New from ACHP:
- A Conversation about Women’s History Month with Fallon Health’s Randi Berkowitz
- ACHP Comments on Advancing Interoperability and Improving Prior Authorization Processes
- ACHP Submits Comments on 2024 Medicare Advantage Notice
- ACHP Comments on the 2024 Medicare Advantage Advance Notice
- Reflecting on Black History Month 2023 and the Work Ahead for Health Equity
- Listening to Black Women with Lived Experiences to Advance Research on Maternal Health Equity
Press Contact
All media inquiries should be directed to:
